Diagnostics
A model based on standard tests predicts hepatitis C-related cirrhosis
Published in Hepatitis Weekly, September 19th, 2005
"Knowledge of the presence of cirrhosis is important for the management of patients with chronic hepatitis C (CHC). Most models for predicting cirrhosis were derived from small numbers of patients and included subjective variables or laboratory tests that are not readily available," researchers in the United States report.
"The aim of this study was to develop a predictive model of cirrhosis in patients with CHC based on standard laboratory tests. Data from 1141 CHC patients including 429 with cirrhosis were analyzed. All biopsies were read by a panel of pathologists (blinded to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2005-09-19)
More Articles from Hepatitis Weekly
- Diagnostics
Plasma chemokines predict the efficacy of hepatitis C antiviral therapy - Hepatitis B Therapy
Single and dual small interfering RNAs target hepatitis B virus genes - Hepatitis C Therapy
Low accelerating doses of antiviral therapy treat advanced hepatitis C - Hepatitis C Therapy
Nitric oxide augments the efficacy of interferon-alpha antiviral therapy - Obstetrics
Hepatitis B antibodies in infants and toddlers may be maternal markers - Chronic Hepatitis C
Recent findings illuminate research in chronic hepatitis c - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
